| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 1341-1351, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
JB Rottman, KP Ganley, K Williams, L Wu, CR Mackay and DJ Ringler
LeukoSite Inc., Cambridge, MA 02142, USA.
The chemokine receptor CCR5 has recently been described as a co- receptor for macrophage-tropic strains of human immunodeficiency virus (HIV)-1. In this study, using a panel of monoclonal antibodies specific for human CCR5, we show by immunohistochemistry and flow cytometry that CCR5 is expressed by bone-marrow-derived cells known to be targets for HIV-1 infection, including a subpopulation of lymphocytes and monocyte/macrophages in blood, primary and secondary lymphoid organs, and noninflamed tissues. In the central nervous system, CCR5 is expressed on neurons, astrocytes, and microglia. In other tissues, CCR5 is expressed on epithelium, endothelium, vascular smooth muscle, and fibroblasts. Chronically inflamed tissues contain an increased number of CCR5+ mononuclear cells, and the number of immunoreactive cells is directly associated with a histopathological correlate of inflammatory severity. Collectively, these results suggest that CCR5+ cells are recruited to inflammatory sites and, as such, may facilitate transmission of macrophage-tropic strains of HIV-1.
This article has been cited by other articles:
![]() |
W.-T. Choi, M. Kaul, S. Kumar, J. Wang, I. M. K. Kumar, C.-Z. Dong, J. An, S. A. Lipton, and Z. Huang Neuronal Apoptotic Signaling Pathways Probed and Intervened by Synthetically and Modularly Modified (SMM) Chemokines J. Biol. Chem., March 9, 2007; 282(10): 7154 - 7163. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ishida, A. Kimura, T. Kondo, T. Hayashi, M. Ueno, N. Takakura, K. Matsushima, and N. Mukaida Essential Roles of the CC Chemokine Ligand 3-CC Chemokine Receptor 5 Axis in Bleomycin-Induced Pulmonary Fibrosis through Regulation of Macrophage and Fibrocyte Infiltration Am. J. Pathol., March 1, 2007; 170(3): 843 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. BALISTRERI, M. P. GRIMALDI, S. VASTO, F. LISTI, M. CHIAPPELLI, F. LICASTRO, D. LIO, C. CARUSO, and G. CANDORE Association between the Polymorphism of CCR5 and Alzheimer's Disease: Results of a Study Performed on Male and Female Patients from Northern Italy Ann. N.Y. Acad. Sci., November 1, 2006; 1089(1): 454 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tomkowicz, C. Lee, V. Ravyn, R. Cheung, A. Ptasznik, and R. G. Collman The Src kinase Lyn is required for CCR5 signaling in response to MIP-1beta and R5 HIV-1 gp120 in human macrophages Blood, August 15, 2006; 108(4): 1145 - 1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Potteaux, C. Combadiere, B. Esposito, C. Lecureuil, H. Ait-Oufella, R. Merval, P. Ardouin, A. Tedgui, and Z. Mallat Role of Bone Marrow-Derived CC-Chemokine Receptor 5 in the Development of Atherosclerosis of Low-Density Lipoprotein Receptor Knockout Mice Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1858 - 1863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gulati, M. Sacchetti, S. Bonini, and R. Dana Chemokine Receptor CCR5 Expression in Conjunctival Epithelium of Patients With Dry Eye Syndrome. Arch Ophthalmol, May 1, 2006; 124(5): 710 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Rasmussen, S. Timm, A. G. Wang, K. Soeby, H. Lublin, M. Fenger, R. Hemmingsen, and T. Werge Association Between the CCR5 32-bp Deletion Allele and Late Onset of Schizophrenia Am J Psychiatry, March 1, 2006; 163(3): 507 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Hardison, R. A. Wrightsman, P. M. Carpenter, W. A. Kuziel, T. E. Lane, and J. E. Manning The CC Chemokine Receptor 5 Is Important in Control of Parasite Replication and Acute Cardiac Inflammation following Infection with Trypanosoma cruzi Infect. Immun., January 1, 2006; 74(1): 135 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J.A. van Wanrooij, H. Happe, A. D. Hauer, P. de Vos, T. Imanishi, H. Fujiwara, T. J.C. van Berkel, and J. Kuiper HIV Entry Inhibitor TAK-779 Attenuates Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2642 - 2647. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Monceaux, L. Viollet, F. Petit, R. H. T. Fang, M.-C. Cumont, J. Zaunders, B. Hurtrel, and J. Estaquier CD8+ T Cell Dynamics during Primary Simian Immunodeficiency Virus Infection in Macaques: Relationship of Effector Cell Differentiation with the Extent of Viral Replication J. Immunol., June 1, 2005; 174(11): 6898 - 6908. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jotwani, M. Muthukuru, and C.W. Cutler Increase in HIV Receptors/Co-receptors/{alpha}-defensins in Inflamed Human Gingiva J. Dent. Res., May 1, 2004; 83(5): 371 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, H. Liu, B. O. Kim, V. H. Gattone, J. Li, A. Nath, J. Blum, and J. J. He CD4-Independent Infection of Astrocytes by Human Immunodeficiency Virus Type 1: Requirement for the Human Mannose Receptor J. Virol., April 15, 2004; 78(8): 4120 - 4133. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zhang, F. Rana, C. Silva, J. Ethier, K. Wehrly, B. Chesebro, and C. Power Human Immunodeficiency Virus Type 1 Envelope-Mediated Neuronal Death: Uncoupling of Viral Replication and Neurotoxicity J. Virol., June 15, 2003; 77(12): 6899 - 6912. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Cardona, P. A. Gonzalez, and J. M. Teale CC Chemokines Mediate Leukocyte Trafficking into the Central Nervous System during Murine Neurocysticercosis: Role of {gamma}{delta} T Cells in Amplification of the Host Immune Response Infect. Immun., May 1, 2003; 71(5): 2634 - 2642. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, Q. Zhai, Y. Luo, and M. E. Dorf RANTES-mediated Chemokine Transcription in Astrocytes Involves Activation and Translocation of p90 Ribosomal S6 Protein Kinase (RSK) J. Biol. Chem., May 17, 2002; 277(21): 19042 - 19048. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cockwell, J. W. Calderwood, C. J. Brooks, S. J. Chakravorty, and C. O. S. Savage Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines Nephrol. Dial. Transplant., May 1, 2002; 17(5): 734 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Kuhmann, N. Madani, O. M. Diop, E. J. Platt, J. Morvan, M. C. Muller-Trutwin, F. Barre-Sinoussi, and D. Kabat Frequent Substitution Polymorphisms in African Green Monkey CCR5 Cluster at Critical Sites for Infections by Simian Immunodeficiency Virus SIVagm, Implying Ancient Virus-Host Coevolution J. Virol., September 15, 2001; 75(18): 8449 - 8460. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Shieh, Y.-E. Liau, P.-S. Hsieh, Y.-P. Yan, S.-T. Wang, and C. Li Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4 Int. Immunol., September 1, 2000; 12(9): 1311 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kielian and W. F. Hickey Proinflammatory Cytokine, Chemokine, and Cellular Adhesion Molecule Expression during the Acute Phase of Experimental Brain Abscess Development Am. J. Pathol., August 1, 2000; 157(2): 647 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Greenhead, P. Hayes, P. S. Watts, K. G. Laing, G. E. Griffin, and R. J. Shattock Parameters of Human Immunodeficiency Virus Infection of Human Cervical Tissue and Inhibition by Vaginal Virucides J. Virol., June 15, 2000; 74(12): 5577 - 5586. [Abstract] [Full Text] |
||||
![]() |
F. EITNER, Y. CUI, K. L. HUDKINS, M. B. STOKES, S. SEGERER, M. MACK, P. L. LEWIS, A. A. ABRAHAM, D. SCHLÖNDORFF, G. GALLO, et al. Chemokine Receptor CCR5 and CXCR4 Expression in HIV-Associated Kidney Disease J. Am. Soc. Nephrol., May 1, 2000; 11(5): 856 - 867. [Abstract] [Full Text] |
||||
![]() |
C. M. McManus, K. Weidenheim, S. E. Woodman, J. Nunez, J. Hesselgesser, A. Nath, and J. W. Berman Chemokine and Chemokine-Receptor Expression in Human Glial Elements : Induction by the HIV Protein, Tat, and Chemokine Autoregulation Am. J. Pathol., April 1, 2000; 156(4): 1441 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Schecter, T. M. Calderon, A. B. Berman, C. M. McManus, J. T. Fallon, M. Rossikhina, W. Zhao, G. Christ, J. W. Berman, and M. B. Taubman Human Vascular Smooth Muscle Cells Possess Functional CCR5 J. Biol. Chem., February 25, 2000; 275(8): 5466 - 5471. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Rajan, V. C. Asensio, I. L. Campbell, and C. F. Brosnan Experimental Autoimmune Encephalomyelitis on the SJL Mouse: Effect of {gamma}{delta} T Cell Depletion on Chemokine and Chemokine Receptor Expression in the Central Nervous System J. Immunol., February 15, 2000; 164(4): 2120 - 2130. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Huffnagle, L. K. McNeil, R. A. McDonald, J. W. Murphy, G. B. Toews, N. Maeda, and W. A. Kuziel Cutting Edge: Role of C-C Chemokine Receptor 5 in Organ-Specific and Innate Immunity to Cryptococcus neoformans J. Immunol., November 1, 1999; 163(9): 4642 - 4646. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hladik, G. Lentz, E. Delpit, A. McElroy, and M. J. McElrath Coexpression of CCR5 and IL-2 in Human Genital But Not Blood T Cells: Implications for the Ontogeny of the CCR5+ Th1 Phenotype J. Immunol., August 15, 1999; 163(4): 2306 - 2313. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Klein, K. C. Williams, X. Alvarez-Hernandez, S. Westmoreland, T. Force, A. A. Lackner, and A. D. Luster Chemokine Receptor Expression and Signaling in Macaque and Human Fetal Neurons and Astrocytes: Implications for the Neuropathogenesis of AIDS J. Immunol., August 1, 1999; 163(3): 1636 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kaul and S. A. Lipton Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis PNAS, July 6, 1999; 96(14): 8212 - 8216. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vassiliadou, L. Tucker, and D. J. Anderson Progesterone-Induced Inhibition of Chemokine Receptor Expression on Peripheral Blood Mononuclear Cells Correlates with Reduced HIV-1 Infectability In Vitro J. Immunol., June 15, 1999; 162(12): 7510 - 7518. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Marshall, B. M. N. Brinkman, C. M. Ambrose, P. A. Pesavento, A. M. Uglialoro, E. Teng, R. W. Finberg, J. L. Browning, and A. E. Goldfeld Signaling Through the Lymphotoxin-{beta} Receptor Stimulates HIV-1 Replication Alone and in Cooperation with Soluble or Membrane-Bound TNF-{alpha} J. Immunol., May 15, 1999; 162(10): 6016 - 6023. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Krzysiek, E. A. Lefevre, W. Zou, A. Foussat, J. Bernard, A. Portier, P. Galanaud, and Y. Richard Antigen Receptor Engagement Selectively Induces Macrophage Inflammatory Protein-1{alpha} (MIP-1{alpha}) and MIP-1{beta} Chemokine Production in Human B Cells J. Immunol., April 15, 1999; 162(8): 4455 - 4463. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Penn, J.-C. Grivel, B. Schramm, M. A. Goldsmith, and L. Margolis CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue PNAS, January 19, 1999; 96(2): 663 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Galasso, J. K. Harrison, and F. S. Silverstein Excitotoxic Brain Injury Stimulates Expression of the Chemokine Receptor CCR5 in Neonatal Rats Am. J. Pathol., November 1, 1998; 153(5): 1631 - 1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Harrison, Y. Jiang, S. Chen, Y. Xia, D. Maciejewski, R. K. McNamara, W. J. Streit, M. N. Salafranca, S. Adhikari, D. A. Thompson, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia PNAS, September 1, 1998; 95(18): 10896 - 10901. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |